ENTO has been granted a new patent
Jun 26, 2024, 10:38 PM
-39.55%
What does ENTO do
First Wave BioPharma Inc, based in Boca Raton, Florida, is a clinical-stage biopharmaceutical company focusing on developing non-systemic therapies for gastrointestinal diseases, including adrulipase and niclosamide. Since its IPO in 2016, the company employs 10 people and conducts Phase 2 clinical trials for treatments targeting cystic fibrosis, chronic pancreatitis, and coronavirus-related GI infections.
ENTO filed a patent for "non-porcine formulations and methods thereof" on Fri, December 9, 2022. The patent was officially published on Thu, July 6, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.